DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20163083

Frequency of anti-nuclear antibody and anti dsDNA antibodies in subjects of oral addictive habits

Muhammad Kashif, Nadeem Afzal, Sadia Minhas, Malik Adeel Anwar, Faheem Shahzad, Afia Abbas, Shah Jahan

Abstract


Background: People with addictive habits are prone to both infectious and non-infectious diseases. Conflicting results have been reported about propensity of these individuals for development of autoimmune diseases. Therefore, a study was planned to determine the frequency of anti-nuclear antibody (ANA) and anti-dsDNA (dsDNA) antibody in the serum of habitual smokers, paan (areca nut) chewers and other oral addictive habits as compared to subjects without such addictive habits.

Methods: Blood samples from 90 subjects (45 with addictive habits and 45 without any addiction) were taken by random sampling after getting written informed consent. Enzyme linked immunosorbent assay (ELISA) was used to test the sera for ANA and anti dsDNA.

Results: One subject in the addictive group had ANA and dsDNA antibodies, whereas in the control group, two subjects had anti dsDNA while none of them had ANA. No significant association of these antibodies was observed between the two groups.

Conclusions: Addictive habits do not predispose the subjects to develop autoimmune diseases.


Keywords


ANA, dsDNA, Autoantibodies, Autoimmunity, Smoking

Full Text:

PDF

References


Ghazala U, Kumar S, Ashraf MI, Agha S, Taj A. Prevalence of Pan, Gutka, Betalnut, Naswar and Cigarette Smoking in University Students of Karachi. Med Forum. 2015;26(1):41-4.

Imam SZ, Nawaz H, Sepah YJ, Pabaney AH, Ilyas M, Ghaffar S. Use of smokeless tobacco among groups of Pakistani medical students: a cross sectional study. BMC Public Health. 2007;7(1):1.

Kyaing NN, Islam MA, Sinha DN, Rinchen S. Social, economic and legal dimensions of tobacco and its control in South-East Asia region. Indian J Public Health. 2011;55(3):161.

Talhout R, Schulz T, Florek E, Van Benthem J, Wester P, Opperhuizen A. Hazardous compounds in tobacco smoke. Int J Environ Res Publ Health. 2011;8(2):613-28.

Pryor WA, Stone K. Oxidants in cigarette smoke radicals, hydrogen peroxide, peroxynitrate, and peroxynitritea. Ann. N. Y. Acad. Sci. 1993;686(1):12-27.

Bijl M, Horst G, Limburg PC, Kallenberg CG. Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes. Eur J Clin Invest. 2001;31(6):550-3.

Lee J, Taneja V, Vassallo R. Cigarette smoking and inflammation cellular and molecular mechanisms. J Dent Res. 2012;91(2):142-9.

Costenbader KH, Karlson EW. Cigarette smoking and autoimmune disease: what can we learn from epidemiology?. Lupus. 2006;15(11):737-45.

Draborg AH, Duus K, Houen G. Epstein-Barr virus in systemic autoimmune diseases. Clin Dev Immunol. 2013;2013:1-9.

Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM, et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun. 2012;39(4):259-71.

Bengtsson AA, Rylander L, Hagmar L, Nived O, Sturfelt G. Risk factors for developing systemic lupus erythematosus: a case–control study in southern Sweden. Rheumatology. 2002;41(5):563-71.

Young KA, Terrell DR, Guthridge JM, Kamen DL, Gilkeson GS, Karp DR, et al. Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls. Lupus. 2014;23(4):360-9.

Ekblom-Kullberg S, Kautiainen H, Alha P, Leirisalo-Repo M, Miettinen A, Julkunen H. Smoking, disease activity, permanent damage and dsDNA autoantibody production in patients with systemic lupus erythematosus. Rheumatol Int. 2014;34(3):341-5.

Perricone C, Versini M, Ben-Ami D, Gertel S, Watad A, Segel MJ, et al. Smoke and autoimmunity: The fire behind the disease. Autoimmun Rev. 2016;15(4):354-74.

Shoenfeld Y, Tincani A. Introduction autoantibodies: the smoke and the fire. Autoimmunity. 2005;38(1):1-2.

Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum. 2012;64(7):2319-27.

Hayashi N, Koshiba M, Nishimura K, Sugiyama D, Nakamura T, Morinobu S, et al. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol. 2008;18(2):153-60.

Minz RW, Kumar Y, Anand S, Singh S, Bamberi P, Verma S, et al. Antinuclear antibody positive autoimmune disorders in North India: an appraisal. Rheumatol Int. 2012;32(9):2883-8.

Azizah MR, Azila MN, Zulkifli MN, Norita TV. The prevalence of antinuclear, anti-dsDNA, anti-Sm and anti-RNP antibodies in a group of healthy blood donors. Asian Pac J Allergy and Immunol. 1996;14(2):125.

Eriksson C, Kokkonen H, Johansson M, Hallmans G, Wadell G, Rantapää-Dahlqvist S. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Res & Ther. 2011;13(1):1.

Sawicka-Gutaj N, Gutaj P, Sowiński J, Wender-Ożegowska E, Czarnywojtek A, Brązert J, et al. Influence of cigarette smoking on thyroid gland—an update. Endokrynol Pol. 2014;65(1):54-62.

Harel-Meir M, Sherer Y, Shoenfeld Y. Tobacco smoking and autoimmune rheumatic diseases. Nat Clin Pract Rheumatol. 2007;3(12):707-15.

Muhammad A, van Wesemael T, Kochi Y, Mjaavatten MD, Wevers-de Boer K, Allaart CF, et al. 29 In rheumatoid arthritis, smoking is not primarily associated with anti-citrullinaged protein antibodies, but with the presence of several autoantibodies. Ann Rheum Dis. 2014;73(1):A12.